PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI — Stella

Home/Pancreatic Neoplasms/

View on ClinicalTrials.gov

Recruiting

Back to Pancreatic Neoplasms trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Sweden

Karolinska University Hospital Huddinge, Stockholm

Key details

Phase

Early testing

Sponsor

Karolinska University Hospital

Enrollment target

~410 participants

Started

June 2021

Primary completion

June 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years and older

Last updated December 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.